AndrewPollard
Long

Long $NSPH for .40's and beyond

NASDAQ:NSPH   NANOSPHERE INC
9 0 0
NSPH             has moderate negative correlation with larger NASX             biotech's. BIB charts implying corrective phase coming. NSPH             is a beaten down stock with good risk-reward here and I believe Verigene System (FDA cleared) could be game-changer for Nanosphere             .


A few excerpts from http://finance.yahoo.com/news/scripps-study-illustrates-clinical-economic-120000635.html :


"The statistically significant findings included a 25.7 hour reduction in time to targeted therapy (61.1 versus 35.4 hours), a 1.9 day median reduction in length of stay (9.1 versus 7.2 days) and $7,240 reduction in median hospital costs per patient ($17,530 versus $10,290)."

''A majority of health care in the U.S. is provided in community-based hospitals. These study findings demonstrate the profound impact on patient care and hospital costs the Verigene System can deliver to a wide spectrum of health care settings,' said Michael McGarrity, Nanosphere's president and chief executive officer."
English
English (UK)
English (IN)
Deutsch
Français
Español
Italiano
Polski
Türkçe
Русский
Português
Bahasa Indonesia
Bahasa Melayu
ภาษาไทย
Tiếng Việt
日本語
한국어
简体
台灣
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out